Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
Also Known As
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Website URL
Legal Names
Legal name
Similar Companies1000
Osfirm
Osperm is a biotechnology company that specializes in developing biocompatible medical devices, including biodegradable bones.
Sector
Subsector
Keywords
Location
total rounds
Particle3D
Particle3D develops 3D-printed bone implants from natural materials.
Sector
Subsector
Keywords
Location
total rounds
total raised
NANOCHON
Nanochon is a medical device company that uses 3D printing and nanomaterials to treat joint damages.
Sector
Subsector
Location
total rounds
total raised
POLTISS
Poltiss is a medical device company specialising in the development of photo-cured, adhesive polymer biomaterials.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds5
Number of Funding Rounds
Money Raised
Their latest funding was raised on 25.07.2024. Their latest investor Boundary Capital Partners LLP. Their latest round Series A
DSW Ventures
DSW Ventures invests in early-stage scale-up businesses requiring venture funding of more than £250,000.
Sector
Subsector
Location
count Of Investments
Co-Investors
Investors6
Number of lead investors
Number of investors
Boundary Capital Partners LLP
Boundary Capital Partners is a London-based VC firm investing in early stage tech companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
DSW Ventures
DSW Ventures invests in early-stage scale-up businesses requiring venture funding of more than £250,000.
Sector
Subsector
Location
count Of Investments
Ellie Boardman
Eleanor Boardman, Investment Executive at DSW Ventures.
SFC Capital
SFC Capital is a UK-based venture capital firm that provides capital and support to British startups.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
People
Founders3
Philip Smith
With over 35 years’ experience in the engineering and materials industries and a track record of delivering fast business growth in a diverse range of start-ups, Phil is playing a key role in shaping 4D Medicine’s strategy and driving the business forward. Previous start-up roles include CEO at Interface Polymers, a polymer additive spin-out from the University of Warwick and Managing Director at a precision instrument spin-out from Cranfield University, majority owned by a FTSE 100 company. Between those appointments, Phil enjoyed a total of 12 years working as an independent consultant and a business development specialist with Warwick Ventures. Phil initially trained as an Engineering Technician in the aerospace instrumentation sector and became a Chartered Engineer in the late 90’s. Throughout his career, Phil has been excited by innovation and the satisfaction of working closely with customers to disrupt markets that are ready for change. Phil has an MBA (with distinction) from Warwick Business School, a BSc Hons in Materials Science and Technology from Brunel University and a Higher National Certificate in Mechanical and Production Engineering.
current job
organization founded
Philip Smith
Tim O'Connell
Tim O’Connell is our part-time Chief Financial Officer. A Chartered Accountant, who for 20 years held senior executive roles in the computer games industry seeing different facets of Publishing, Development and Distribution, thereby gaining experience in a wide range of operational disciplines. Tim helped grow companies including one group as FD from 10 employees to 300 and flotation and ultimate sale. He was responsible for opening a number of international offices/joint ventures and helped acquire/sell companies and close non-performing ones. Tim also gained considerable experience with legal contracts, commercial and corporate including IP. Since setting up a consultancy in 2003, Tim has helped mentor and develop business and strategic plans for a number of start-up and early growth companies, helping raise finance through equity, debt and grants. Tim also works with VC’s/Angels
current job
organization founded
Tim O'Connell
Andrew Dove
Professor Andrew Dove is a world-expert in degradable biomaterials/polymers at the School of Chemistry in the University of Birmingham. The creation of 4D Medicine Ltd was the culmination of over 12 years’ research and Andrew is determined to see his novel materials technology translated into a commercial success, delivering better treatment experiences and outcomes for medical patients across the globe. In his part-time role as a Director and CSO, Andrew continues to provide vital scientific guidance and support to the company. Andrew graduated from the University of York with an M.Chem. degree in 1999 and he gained his subsequent Ph.D. at Imperial College, London. Andrew undertook post-doctoral research at Stanford University, California and then as a post-doctoral fellow at IBM, San Jose, California. Andrew returned to the UK in 2006 and was appointed as an Assistant Professor at the University of Warwick, rising to Associate Professor in 2009 and Full Professor in 2014. In January 2018, Andrew joined the School of Chemistry at the University of Birmingham as Professor of Chemistry.
current job
organization founded
Andrew Dove
Employee Profiles4
Activity
Recent News2
The graph reveals the ratio (%) of positive news articles in a chosen time range